IFNG and urinary bladder carcinoma: Other rBCG strains have also been constructed, expressing inflammatory or Th1 cytokines such as IL-2, IL-12, IL-18, IFN-α, and IFN-γ, as potentially improved immunotherapeutic tools for bladder cancer treatment (15, 16).